ArticleEClinicalMedicine2021

Predicting hyperprogressive disease in patients with advanced hepatocellular carcinoma treated with anti-programmed cell death 1 therapy.

Lu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.